C4 Therapeutics (CCCC) Preferred Dividend Payments (2020)
C4 Therapeutics (CCCC) posted quarterly Preferred Dividend Payments of $5.2 million for Q3 2020, up 79.23% quarter-over-quarter from $2.9 million in Q2 2020.
Analysis
C4 Therapeutics (CCCC) Preferred Dividend Payments (2020) Analysis & Trends
C4 Therapeutics' Preferred Dividend Payments history runs 1 years deep, the most recent figure standing at $5.2 million for Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | - |
| 10 | C4 Therapeutics | 492.73 Mn | 239.06 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 5.21 Mn |
| Jun 30, 2020 | 2.91 Mn |
| Mar 31, 2020 | 2.11 Mn |